ClearPoint Neuro Inc

ClearPoint Neuro Inc

CLPT

Get informed when a big investor buys or sells

+ Follow
Market Cap$448.04M
Close$

Compare to Similar Companies

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
ClearPoint Neuro IncClearPoint Neuro Inc-14.8--154%12.93.4
$16.00

Target Price by Analysts

24.3% upsideClearPoint Neuro Target Price DetailsTarget Price
$-10.76

Current Fair Value

183.6% downside

Overvalued by 183.6% based on the discounted cash flow analysis.

Share Statistics

Market cap$448.04 Million
Enterprise Value$476.04 Million
Dividend Yield$- (-)
Earnings per Share$-0.9
Beta1.24
Outstanding Shares29,546,889

Return

Return on Equity-154.27%ROE
Return on Assets-31.11%
Return on Invested Capital-31.55%

Valuation & Multiples

P/E Ratio-14.79P/E Ratio
PEG-25.28PEG
Price to Sales12.88Price to Sales
Price to Book Ratio-Price to Book Ratio
Enterprise Value to Revenue11.72
Enterprise Value to EBIT-17.98
Enterprise Value to Net Income-17
Total Debt to Enterprise0.13
Debt to Equity3.37Debt to Equity

Revenue Sources

No data

Insider Trades

Last Earnings Call

Report Date
August 3, 2026
EPS Estimate
$-0.29
Average shareholder expectation
Revenue Estimate
$12.73 M
Average shareholder expectation

Next Earnings Call

Expected Date
August 11, 2026
EPS Estimate
$-0.27
Average shareholder expectation
Revenue Estimate
$12.73 M
Average shareholder expectation

Institutional Put/Call Ratio

Market sentiment based on institutional option activity.

Put/Call Ratio0.0000 55.08%
Total Calls- 100.00%
Total Puts- 100.00%

Institutional Ownership

Holdings and activity of institutional investors.

Ownership %1.92% 42.06%
Total Invested$9.94M 91.60%
Investors Holding25 100.00%

ESG Score

No data

About ClearPoint Neuro Inc